AlménT.NordahlV.HaavaldsenJ.: Nonionic iodinated X-ray contrast agents. British patent specification1321591 (1969).
5.
AspelinP.: Effect of ionic and non-ionic contrast media on red cell deformability in vitro.. Acta Radiol. Diagn.20 (1979), 1.
6.
BerberichJ.HirschS.: Die röntgenographische Darstellung der Arterien und Venen am lebenden Menschen. Klin. Wschr.49 (1923), 2226.
7.
BinzA.: The chemistry of Uroselectan. J. Urol.25 (1931), 297.
8.
BinzA.: Geschichte des Uroselectans. Z. Urol.31 (1937), 73.
9.
BinzA.RäthC.: Über biochemische Eigenschaften von Derivaten des Pyridins und Chinolins. Biochem. Z.203 (1928), 218.
10.
CameronD.: Aqueous solutions of potassium and sodium iodide as opaque medium in roentgenography. JAMA70 (1918), 754.
11.
FischerH.: Contrast media in coronary arteriography. Invest. Radiol.13 (1978), 450.
12.
FischerH.CornellS.: The toxicity of the sodium and methylglucamine salts of diatrizoate, iothalamate and metrizoate. Radiology85 (1965), 1013.
13.
FischerH.EcksteinJ.: Comparison of cerebral angiographic contrast media by their circulatory effects. AJR86 (1961), 166.
14.
FranckO.AlwensW.: Kreislaufstudien am Röntgenschirm. München Med. Wschr.51 (1910), 950.
15.
HaschekE.LindenthalO.: Ein Beitrag zur praktischen Verwertung der Photographie nach Röntgen. Wien. Klin. Wschr.9 (1896), 63.
16.
HilalS.: Hemodynamic changes associated with the intraarterial injection of contrast media. Radiology86 (1966), 615.
17.
JacobsenT.: The pre-clinical development of iohexol (Omnipaque). Farmakoterapi38 (1982), 45.
18.
LangJ.LasserE.: Nonspecific inhibition of enzymes by organic contrast media. J. Med. Chem.14 (1971), 233.
19.
LasserE.LangJ.FujimagariT.TrippW.: The significance of protein binding of contrast media in roentgen diagnosis. AJR87 (1962), 33.
20.
LongL.BurgerA.: Synthesis of some iodinated aromatic compounds. J. Am. Chem. Soc.63 (1941), 1586.
21.
MalyP.ElmqvistD.AlménT.GolmanK.: Comparison between EEG and observation of rabbit behaviour in evaluation of subarachnoid neurotoxicity of metrizamide. Neuroradiology26 (1984), 235.
22.
NalbandianR.RiceW.NickelW.: A new category of contrast media. Water-soluble radiopaque polyvalent chelates. Ann. N. Y. Acad. Sci.78 (1959), 779.
23.
NymanU.AlménT.LandtmanS.: Effect of pH, buffer and osmolality of different contrast media on aortic blood pressure in the rabbit. Acta Radiol. Diagn.21 (1980), 679.
24.
OsborneE.SutherlandC.SchollA.RowntreeL.: Roentgenography of urinary tract during excretion of sodium iodide. JAMA80 (1923), 368.
25.
PaulinS.AdamsD.: Increased ventricular fibrillation during coronary arteriography with a new contrast medium preparation. Radiology101 (1971), 45.
26.
ReadR.: Cause of death in cardioangiography. J. Thorac. Cardiovasc. Surg.38 (1959), 685.
27.
ReadR.JohnsonJ.VicL.MeyerM.: Vascular effects of hypertonic solutions. Circ. Res.8 (1960), 538.
28.
ReadR.MeyerM.: The role of red cell agglutination in arteriographic complications. Surg. Forum10 (1960), 472.
29.
RenaaT.JacobsenT.: Contrast media research. Acta Radiol. (1987), Suppl. 370, p. 9.
30.
RubinM.Di ChiroG.: Chelates as possible contrast media. Ann. N. Y. Acad. Sci.78 (1959), 764.
31.
SaitoM.KamikawaK.YanakizawaH.: A new method for blood vessel visualization (arteriography, venography, angiography) in vivo. Am. J. Surg.10 (1930), 225.
32.
SalvesenS.: Acute intravenous toxicity of contrast media in rats. Data on file 9.1.1984, Nycomed Imaging AS, Oslo.
33.
SalvesenS.: Acute toxicity tests of metrizamide. Acta Radiol. (1973), Suppl. 335, p. 5.
34.
SalvesenS.: Experimental investigations with metrizamide with relevance to myelographic use. Acta Radiol. (1973), Suppl. 355, p. 9.
35.
SalvesenS.: Suboccipital injection of metrizamide to anaesthetized and unanaesthetized rabbits. Acta Radiol. (1973), Suppl. 335, p. 93.
36.
SalvesenS.Lund NilsenPHoltermannH.: Ameliorating effects of calcium and magnesium ions on the toxicity of Isopaque sodium. I. Acute toxicities and toxicities in the brain. Acta Radiol. (1967), Suppl. 270, p. 17.
37.
SalvesenS.Lund NilsenPHoltermannH.: Ameliorating effect of calcium and magnesium ions on the toxicity of Isopaque sodium. II. Studies on the isolated rabbit heart and auricles of the rabbit. Acta Radiol. (1967), Suppl. 270, p. 30.
38.
SalvesenS.Lund NilsenPHoltermannH.: Effects of calcium and magnesium ions on the systemic and local toxicities of the N-methyl-glucamine (meglumine) salt of metrizoic acid (Isopaque). Acta Radiol. (1967), Suppl. 270, p. 180.
39.
SandborgM.ChristofferssonJ.-O.Alm-CarlssonG.AlménT.DanceD.: Physical performance of different X-ray contrast agents. Calculations using a Monte Carlo model of the imaging chain. Phys. Med. Biol.40 (1995), 1209.
40.
ShapiroR.PapaD.: Heavy metal chelates and cesium salts for contrast radiography. Ann. N. Y. Acad. Sci.78 (1959), 756.
41.
SimonA.ShabetaiR.LangJ.LasserE.: The mechanism of production of ventricular fibrillation in coronary angiography. AJR114 (1972), 810.
42.
StormE.IsraelH.: Photon cross sections from 1 keV to 100 MeV for elements Z=1 to Z=100. In: Nuclear data tables. Vol. 7, Section A, p. 565. Academic Press, NewYork1970.
43.
SwickJ.: Darstellung der Niere und Harnwege im Röntgenbild durch intravenöse Einbringung eines neuen Kontraststoffes, des Uroselectans. Klin. Wschr.8 (1929), 2087.
44.
VosseA.: Étude expérimentale de la tolérance des produits de contraste tri-iodés par la barrière hémato-cérébrale. Rev. Méd. Liège15 (1960), 645.
45.
WallingfordV.: Aspects of contrast medium research. Ann. N. Y. Acad. Sci.78 (1959), 707.
46.
WallingfordV.: The development of organic iodine compounds as X-ray contrast media. J. Am. Pharm. Ass.42 (1953), 721.
47.
WallingfordV.BeckerH.KrutyM.: X-ray contrast media. I. Iodinated acylaminobenzoic acids. J. Am. Chem. Soc.74 (1952), 4365.
48.
WolfG. L.: The fibrillatory propensities of contrast agents. Invest. Radiol. (1980), Suppl., p. S208.